Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Anna E. Storozhakova"'
Autor:
Natalia I. Samaneva, Liubov I. Vladimirova, Irina V. Kolyadina, Elena M. Frantsiyants, Anna E. Storozhakova, Valeriya A. Bandovkina, Elena A. Kalabanova, Sergei N. Kabanov, Iana V. Svetitskaya, Anna V. Tishina, Mariia O. Ezhova
Publikováno v:
Современная онкология, Vol 23, Iss 1, Pp 82-87 (2021)
Relevance. Breast cancer (BC) is among the most common cancers and the leading causes of cancer death in women worldwide. Much attention is paid to the problem of its hormoneresistance; however, the issues of using prognostic markers and predictors i
Externí odkaz:
https://doaj.org/article/a9fdf814b2364cbe9492945661d48d9f
Autor:
Irina V. Kolyadina, Natalia R. Abidova, Arshak A. Akopyan, Galina V. Antonova, Oksana I. Arapova, Elvira A. Bobrova, Larisa V. Bolotina, Chulpan K. Valiakhmetova, Anna V. Vasilevskaya, Lyubov Y. Vladimirova, Mikhail V. Volkonskiy, Inna P. Ganshina, Irina E. Gudkova, Alexandr S. Dergunov, Irina V. Evstigneeva, Viktoria S. Egurenkova, Aleksei V. Emshanov, Lyudmila G. Zhukova, Elena V. Zueva, Elena V. Karabina, James J. Kolokolov, Svetlana V. Kuzmicheva, Olesya A. Kuchevskaya, Ivan A. Luev, Ksenia S. Maistrenko, Elena V. Markizova, Vasily V. Marfutov, Sergey P. Medvedev, Yulia I. Merzlikina, Tatyana A. Nersesova, Elena G. Ovchinnikova, Svetlana A. Orlova, Natalia Y. Samaneva, Olesya A. Stativko, Anna E. Storozhakova, Daniil L. Stroyakovskiy, Alexander V. Sultanbaev, Asiat I. Tekeeva, Natalia V. Fadeeva, Alina N. Fedorova, Oksana M. Shalaeva, Irina A. Shangina, Oksana N. Shirokova, Alisa R. Shumskikh, Mariam Z. Yakubova
Publikováno v:
Современная онкология, Vol 23, Iss 1, Pp 68-76 (2021)
Relevance. Data on the efficacy of endocrine and chemotherapy regimens in patients with hormone-resistant metastatic breast cancer (mBC) after progression with CDK4/6 inhibitors are limited; the search for an effective therapy regimen in this clinica
Externí odkaz:
https://doaj.org/article/714a7172db8b443795259379d343327b
Autor:
Oleg I. Kit, Liubov Iu. Vladimirova, Anna E. Storozhakova, Tatiana A. Snezhko, Elena A. Kalabanova, Natalia Iu. Samaneva, Iana V. Svetitskaia, Sergei N. Kabanov
Publikováno v:
Современная онкология, Vol 21, Iss 4, Pp 10-14 (2020)
Aim. Evaluation of treatment options and efficacy in patients with hepatocellular carcinoma based on data from the FSBI Rostov Cancer Research Institute using a multidisciplinary approach to the problem. Materials and methods. 124 cases of hepatoc
Externí odkaz:
https://doaj.org/article/aae0b94624bb40dbac710ff21cefb9be
Autor:
Valeriya Bandovkina, Anna V. Tishina, Sergei N. Kabanov, Anna E. Storozhakova, Irina V. Kolyadina, Liubov' I Vladimirova, Natalia Iu. Samaneva, Iana V. Svetitskaya, Elena M. Frantsiyants, Mariia O. Ezhova, Elena A. Kalabanova
Publikováno v:
Современная онкология, Vol 23, Iss 1, Pp 82-87 (2021)
Relevance. Breast cancer (BC) is among the most common cancers and the leading causes of cancer death in women worldwide. Much attention is paid to the problem of its hormoneresistance; however, the issues of using prognostic markers and predictors i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f2b7e6310f493844ea7a7c46f4c466
https://doi.org/10.26442/18151434.2021.1.200716
https://doi.org/10.26442/18151434.2021.1.200716
Autor:
Inna P. Ganshina, Elena G. Ovchinnikova, Oksana M. Shalaeva, Svetlana V. Kuzmicheva, Alina N. Fedorova, Asiat I. Tekeeva, Alexander V. Sultanbaev, Elena V. Markizova, L G Zhukova, Ksenia S. Maistrenko, Svetlana A. Orlova, Irina V. Evstigneeva, Daniil L'vovich Stroyakovskiy, James J. Kolokolov, Olesya A. Kuchevskaya, Oksana N. Shirokova, Oksana I. Arapova, Elena V. Zueva, Anna V. Vasilevskaya, Tatyana A. Nersesova, Arshak A. Akopyan, Irina V. Kolyadina, Larisa Bolotina, Mariam Z. Yakubova, Sergey P. Medvedev, Alexandr S. Dergunov, Irina A. Shangina, Elvira A. Bobrova, Chulpan K. Valiakhmetova, Anna E. Storozhakova, Aleksei V. Emshanov, Natalia V. Fadeeva, Mikhail V. Volkonskiy, Yulia I. Merzlikina, Galina V. Antonova, Ivan A. Luev, Alisa R. Shumskikh, Natalia Yu. Samaneva, Elena Karabina, Natalia R. Abidova, Viktoria S. Egurenkova, Vasily V. Marfutov, Irina E. Gudkova, Lyubov Vladimirova, Olesya A. Stativko
Publikováno v:
Современная онкология, Vol 23, Iss 1, Pp 68-76 (2021)
Relevance. Data on the efficacy of endocrine and chemotherapy regimens in patients with hormone-resistant metastatic breast cancer (mBC) after progression with CDK4/6 inhibitors are limited; the search for an effective therapy regimen in this clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfb5294fb4dbd7b9369d65fe23e952c1
https://modernonco.orscience.ru/1815-1434/article/viewFile/70308/51242
https://modernonco.orscience.ru/1815-1434/article/viewFile/70308/51242
Autor:
Natalia Yu. Samaneva, Anna V. Tishina, Lubov' Yu Vladimirova, Yana V. Svetitskaya, Sergey V. Oskin, Sergey N. Kabanov, Anna E. Storozhakova, Pavel N. Meshcheryakov, Elena A. Kalabanova
Publikováno v:
South Russian Journal of Cancer. 2:35-42
Lung cancer is among the most common malignant diseases in Russia. In 80–90%, its morphological type is nonsmall cell lung cancer. Stage IV primary advanced lung cancer is diagnosed in 41% of patients. Median overall survival in stage IV patients r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95dd9fc67e372b3605582a9431d637df
https://doi.org/10.37748/2686-9039-2021-2-1-4
https://doi.org/10.37748/2686-9039-2021-2-1-4
Autor:
Iana V. Svetitskaia, Anna E. Storozhakova, Oleg I. Kit, Natalia Iu. Samaneva, Elena A. Kalabanova, Liubov' I Vladimirova, Sergei N. Kabanov, Tatiana A. Snezhko
Publikováno v:
Современная онкология, Vol 21, Iss 4, Pp 10-14 (2020)
Aim. Evaluation of treatment options and efficacy in patients with hepatocellular carcinoma based on data from the FSBI Rostov Cancer Research Institute using a multidisciplinary approach to the problem. Materials and methods. 124 cases of hepatocell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91cca75b66db84b108617a7218514ccf
https://modernonco.orscience.ru/1815-1434/article/viewFile/34000/21714
https://modernonco.orscience.ru/1815-1434/article/viewFile/34000/21714
Autor:
Oksana V. Katelnitskaya, Irina S. Tishchenko, Elena A. Shevyakova, Irina B. Lysenko, Tatiana A. Zykova, Anna V. Tishina, Aza A. Lyanova, Lyudmila A. Ryadinskaya, Sergey N. Kabanov, Elena A. Kalabanova, Natalya Mikhailovna Tikhanovskaya, Lyubov Vladimirova, Andrey A. Maslov, Natalia A. Abramova, Kristina A. Novoselova, Anna E. Storozhakova, Irina L. Popova
Publikováno v:
I.P. Pavlov Russian Medical Biological Herald. 28:44-56
Aim. To study the prevalence of carriage of polymorphic allele variants of genes of blood coagulation factors in oncological patients. Materials and Methods. 213 Patients with morphologically confirmed oncological diseases were examined. Samples of g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aba1d663dcb8071db6103bb030407af2
https://doi.org/10.23888/pavlovj202028144-56
https://doi.org/10.23888/pavlovj202028144-56
Autor:
Natalia Yu. Samaneva, Liubov Yu Vladimirova, Anna E. Storozhakova, Elena A. Kalabanova, Sergey N. Kabanov, Anna V. Tishina, Yakha S. Gaysultanova, Maria A. Teplyakova, Aza A. Lyanova, Natalia A. Abramova, Ludmila A. Ryadinskaya, Irina A. Udalenkova, Natalia M. Tikhanovskaya, Irina L. Popova, Marina M. Sergeeva, Larisa N. Vashchenko
Publikováno v:
Journal of Clinical Oncology. 40:e13072-e13072
e13072 Background: Breast cancer (BC) is the most common cancer in women worldwide. The purpose of the study was to analyze immediate and long-term results of treatment in patients with locally advanced primarily inoperable HER2-negative breast cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::731989fd8e8299aef7b165451421b095
https://doi.org/10.1200/jco.2022.40.16_suppl.e13072
https://doi.org/10.1200/jco.2022.40.16_suppl.e13072
Autor:
Maria A. Teplyakova, Liubov Yu Vladimirova, Irina L. Popova, Aza A. Lyanova, Natalia A. Abramova, Anna E. Storozhakova, Ludmila A. Ryadinskaya, Natalia M. Tikhanovskaya, Irina A. Udalenkova, Elena A. Kalabanova, Sergey N. Kabanov, Aleksandr B. Sagakyants, Elena Yu Zlatnik, Oksana G. Shulgina, Ekaterina I. Zolotareva, Elena P. Ulianova, Viktoria V. Pozdnyakova, Yuriy V. Przhedetskiy
Publikováno v:
Journal of Clinical Oncology. 40:e21509-e21509
e21509 Background: The limited range of patients clinically responding to checkpoint inhibitor therapy (CIT) is of interest and requires studying the immunological mechanisms underlying this phenomenon. It also remains to be decided or better clarifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22b066e4f0536b6f32c46c6850f63493
https://doi.org/10.1200/jco.2022.40.16_suppl.e21509
https://doi.org/10.1200/jco.2022.40.16_suppl.e21509